Trials / Unknown
UnknownNCT03817164
Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis
Multicenter, Randomized, Double-Blind, Sham-Controlled, Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Thync Global, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 16-week, prospective, multicenter, double-blind, controlled, randomized study assessing change in psoriasis severity and level of stress in patients with moderate psoriasis treated with ANM. Psoriasis severity and stress levels will be measured at Weeks 0, 2, 8, 12, and 16.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Autonomic Nerve Modulation - Active | Thync ANM is a portable, battery-powered, electrical neuromodulation device connected to single-use gel electrode pads that are applied to the base of the neck. |
| DEVICE | Autonomic Nerve Modulation - Control | Thync ANM is a portable, battery-powered, electrical neuromodulation device connected to single-use gel electrode pads that are applied to the base of the neck. |
Timeline
- Start date
- 2018-10-02
- Primary completion
- 2019-10-30
- Completion
- 2019-10-30
- First posted
- 2019-01-25
- Last updated
- 2019-07-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03817164. Inclusion in this directory is not an endorsement.